These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 20019466
1. Editorial: A different approach to cardiovascular risk factors. Oğuz A, Kiliç DC, Uzunlulu M. Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 6():1-3. PubMed ID: 20019466 [No Abstract] [Full Text] [Related]
4. Hypertension, diabetes, hypercholesterolemia, and their combinations increased health care utilization and decreased health status. Natarajan S, Nietert PJ. J Clin Epidemiol; 2004 Sep; 57(9):954-61. PubMed ID: 15504638 [Abstract] [Full Text] [Related]
5. Anticipatory care for the diabetic-hypertensive bundle. Hart JT. Prim Care Diabetes; 2008 Dec; 2(4):165-6. PubMed ID: 19008169 [No Abstract] [Full Text] [Related]
6. The diabetic, hypertensive heart: epidemiology and mechanisms of a very high-risk situation. Franjic B, Marwick TH. J Hum Hypertens; 2009 Nov; 23(11):709-17. PubMed ID: 19516273 [Abstract] [Full Text] [Related]
7. [Hypertension as a part of metabolic cardiovascular syndrome]. Os I, Hjermann I, Nordby G. Tidsskr Nor Laegeforen; 1991 Oct 20; 111(25):3062-4. PubMed ID: 1948918 [Abstract] [Full Text] [Related]
8. Reducing cardiovascular risk in patients with type 2 diabetes mellitus. Nicholls SJ, Rydén L. Eur J Cardiovasc Prev Rehabil; 2010 May 20; 17 Suppl 1():S1. PubMed ID: 20489414 [No Abstract] [Full Text] [Related]
11. Insulin resistance and hypertension. Patients in double jeopardy for cardiovascular disease. McLaughlin T, Reaven G. Geriatrics; 2000 Jun 20; 55(6):28-32, 35. PubMed ID: 10872343 [Abstract] [Full Text] [Related]
12. Multiple risk factor intervention in type 2 diabetes: an opportunity not to be missed. Cockcroft JR, Wilkinson IB, Yki-Järvinen H. Diabetes Obes Metab; 2001 Feb 20; 3(1):1-8. PubMed ID: 11213594 [No Abstract] [Full Text] [Related]
13. [Diabetes and hypertension. Results from the ADVANCE study]. Mehlsen J. Ugeskr Laeger; 2008 Feb 11; 170(7):531-2. PubMed ID: 18291082 [No Abstract] [Full Text] [Related]
14. Cardiovascular risk prevalence, awareness, treatment, and control from 1998 to 2007 in Koreans. Lee K. Asia Pac J Clin Nutr; 2010 Feb 11; 19(2):261-5. PubMed ID: 20460242 [Abstract] [Full Text] [Related]
15. Therapy and clinical trials: diabetes and cardiovascular risk. Peter R. Curr Opin Lipidol; 2008 Feb 11; 19(1):101-3. PubMed ID: 18196995 [No Abstract] [Full Text] [Related]
16. [Prevention of cardiovascular diseases. 1998 guidelines of the National Cardiovascular Conference (NCC)]. Becker HJ, Schwandt P, Held K, Bönner G. Dtsch Med Wochenschr; 1999 Oct 22; 124(42):1249-52. PubMed ID: 10572535 [No Abstract] [Full Text] [Related]
17. [Combination therapy of cardiovascular risk factors]. Weisser B, Grüne S, Mengden T, Spühler T, Vetter W. Schweiz Rundsch Med Prax; 1992 Jan 14; 81(3):55-9. PubMed ID: 1733004 [Abstract] [Full Text] [Related]
18. Introductory remarks. Velasco M, Bermúdez V, Israili ZH, Hernández-Hernández R. Am J Ther; 2010 Jan 14; 17(3):236. PubMed ID: 20479578 [No Abstract] [Full Text] [Related]
19. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Parikh NI, Hwang SJ, Larson MG, Meigs JB, Levy D, Fox CS. Arch Intern Med; 2006 Sep 25; 166(17):1884-91. PubMed ID: 17000946 [Abstract] [Full Text] [Related]
20. Cardiovascular disease in type 2 diabetics: epidemiology, risk factors and therapeutic modalities. Khamaisi M, Wexler ID, Skrha J, Strojek K, Raz I, Milicevic Z. Isr Med Assoc J; 2003 Nov 25; 5(11):801-6. PubMed ID: 14650106 [Abstract] [Full Text] [Related] Page: [Next] [New Search]